New York, April 18 (FinanceEnquiry.com) – Analyst Herman Saftlas at S&P Capital IQ keeps his BUY rating on the shares of Abbott Laboratories (NYSE: ABT). The 12-month target price is set to $68.
In a research note published today, the analyst states that Q1 non-GAAP EPS of Abbott Laboratories went up 13% to $1.03, beating the estimate of $0.99. The beat to better gross margins, strong sales of nutritionals of more than 10.1% and Humira of above 17% are attributed.
Regardless of assumed negative forex, continued top line growth and margin improvement over the balance of the year are estimated. The 2012 EPS estimate is lifted $0.05 to $5.05, the analyst adds. Moreover, the shareholder value is also seen being boosted by the scheduled spin-off of the pharmaceuticals unit later this year.
New York, May 20 (FinanceEnquiry.com) – Seeing that investors expect China would put into use reforms in order to refresh slumping economy of the nation, Hong Kong shares soared to their uppermost level in 3-...
Automobile Sales Ascend across Europe - May 17, 2013New York, May 17 (FinanceEnquiry.com) – Being enhanced by healthy requirement in the UK, latest car sales across Europe soared in the earlier month for the initial time in 18 months. As compared with a year...
Nikkei Rises on US expansion Optimisms; Watchfulness on Feeble Global Expansion Caps Asian Shares - May 7, 2013New York, May 7 (FinanceEnquiry.com) – Even though refreshed anticipations for a stable US recovery drove Japanese equities to a near five-year crest, still Asian shares were capped on May 7 by warning...
Deutsche Bank Securities Reiterates BUY Rating on Allegiant Travel Company (NASDAQ: ALGT), Target Price Raised - April 25, 2013New York, April 26 (FinanceEnquiry.com) – Analysts at Deutsche Bank Securities reiterate their BUY rating on the shares of Allegiant Travel Company (NASDAQ: ALGT). The 12-month target price has...
Micromax A110 Canvas 2: Transforming Imagination into Reality - April 22, 2013New York, April 22 (FinanceEnquiry.com) – Micromax A110 Canvas 2, a Dual SIM (Mini-SIM) mobile phone, marked its entry in the month of November last year and since then, it has become one of the...
Deutsche Bank Securities Reiterates BUY Rating on Freeport-McMoRan Copper & Gold Inc (NYSE: FCX) - April 16, 2013New York, April 17 (FinanceEnquiry.com) – Analysts at Deutsche Bank Securities reiterate their BUY rating on the shares of Freeport-McMoRan Copper & Gold Inc (NYSE: FCX). The 12-month target price is set...
Asian Shares Plunge, Commodities Drop; China Economic Expansion Eases Suddenly - April 15, 2013New York, April 15 (FinanceEnquiry.com) – As soon as economic expansion of China all of a sudden eased in the 1Q with lower gains in factory-production, Asian stocks fell from the uppermost level in...
US House Costs Soared in Feb by Biggest Amount In Seven Years - April 4, 2013New York, April 4 (FinanceEnquiry.com) – Providing the proof that the housing improvement reinforced prior to the crucial spring-buying period, US house costs soared in the month of February by the biggest...
Asian Shares and the Euro Plunge - April 1, 2013New York, April 1 (FinanceEnquiry.com) – Asian shares and the euro skidded on the very first day of the month in uneven trade with exchanges closed in more than a few Asian markets, together with Australia...
Deutsche Bank Securities Reiterates HOLD Rating on James River Coal Co (NASDAQ: JRCC), Target Price Reduced - March 11, 2013New York, March 12 (FinanceEnquiry.com) – Analysts at Deutsche Bank Securities reiterate their HOLD rating on the shares of James River Coal Co (NASDAQ: JRCC). The 12-month target price has been reduced to...